The incidence of biliary injury after laparoscopic cholecystectomy (LC) has shown a declining trend though it may still be twice that as with open cholecystectomy. Major biliary or vasculobiliary injury is associated with significant morbidity. As prevention is the best strategy, the concept of a culture of safe cholecystectomy has been recently introduced to educate surgeons and apprise them of basic tenets of safe performance of LC. Various aspects of safe cholecystectomy include: (1) thorough knowledge of relevant anatomy, various anatomical landmarks, and anatomical variations; (2) an understanding of the mechanisms involved in biliary/vascular injury, the most important being the misidentification injury; (3) identification of various preoperative and intraoperative predictors of difficult cholecystectomy; (4) proper gallbladder retraction; (5) safe use of various energy devices; (6) understanding the critical view of safety, including its doublet view and documentation; (7) awareness of various error traps (e.g., fundus first technique); (8) use of various bailout strategies (e.g., subtotal cholecystectomy) in difficult gallbladder cases; (9) use of intraoperative imaging techniques (e.g., intraoperative cholangiogram) to ascertain correct anatomy; and (10) understanding the concept of time-out. Surgeons should be facile with these aspects of this culture of safety in cholecystectomy in an attempt to reduce the incidence of biliary/vascular injury during LC.
CBDSs are one of the medical conditions leading to surgical intervention. They may occur in 3%–14.7% of all patients for whom cholecystectomies are preformed. When patients present with CBD, the one important question that should be answered: what is the best modality of treatment under the giving conditions? There are competing technologies and approaches for diagnosing CBDS with regard to diagnostic performance characteristics, technical success, safety, and cost effectiveness. Management of CBDS usually requires two separate teams: the gastroenterologist and the surgical team. One of the main factors in the management is initially the detection of CBDS, before, during, or after cholecystectomy. The main options for treatment are pre- or postoperative ERCP with endoscopic biliary sphincterotomy (EST), laparoscopic or open surgical bile duct clearance. There are other options for the treat- ment of CBDS such as electrohydraulic lithotripsy (EHL), extracorporeal shockwave lithotripsy (ESWL), dissolving solutions, and laser lithotripsy. It is unlikely that one option
will be appropriate for all clinical circumstances in all centers. Variables such as disease status, patient demographics, availability of endoscopic, radiological and surgical expertise, and healthcare economics will all have significant influence on practice
The incidence of biliary injury after laparoscopic cholecystectomy (LC) has shown a declining trend though it may still be twice that as with open cholecystectomy. Major biliary or vasculobiliary injury is associated with significant morbidity. As prevention is the best strategy, the concept of a culture of safe cholecystectomy has been recently introduced to educate surgeons and apprise them of basic tenets of safe performance of LC. Various aspects of safe cholecystectomy include: (1) thorough knowledge of relevant anatomy, various anatomical landmarks, and anatomical variations; (2) an understanding of the mechanisms involved in biliary/vascular injury, the most important being the misidentification injury; (3) identification of various preoperative and intraoperative predictors of difficult cholecystectomy; (4) proper gallbladder retraction; (5) safe use of various energy devices; (6) understanding the critical view of safety, including its doublet view and documentation; (7) awareness of various error traps (e.g., fundus first technique); (8) use of various bailout strategies (e.g., subtotal cholecystectomy) in difficult gallbladder cases; (9) use of intraoperative imaging techniques (e.g., intraoperative cholangiogram) to ascertain correct anatomy; and (10) understanding the concept of time-out. Surgeons should be facile with these aspects of this culture of safety in cholecystectomy in an attempt to reduce the incidence of biliary/vascular injury during LC.
CBDSs are one of the medical conditions leading to surgical intervention. They may occur in 3%–14.7% of all patients for whom cholecystectomies are preformed. When patients present with CBD, the one important question that should be answered: what is the best modality of treatment under the giving conditions? There are competing technologies and approaches for diagnosing CBDS with regard to diagnostic performance characteristics, technical success, safety, and cost effectiveness. Management of CBDS usually requires two separate teams: the gastroenterologist and the surgical team. One of the main factors in the management is initially the detection of CBDS, before, during, or after cholecystectomy. The main options for treatment are pre- or postoperative ERCP with endoscopic biliary sphincterotomy (EST), laparoscopic or open surgical bile duct clearance. There are other options for the treat- ment of CBDS such as electrohydraulic lithotripsy (EHL), extracorporeal shockwave lithotripsy (ESWL), dissolving solutions, and laser lithotripsy. It is unlikely that one option
will be appropriate for all clinical circumstances in all centers. Variables such as disease status, patient demographics, availability of endoscopic, radiological and surgical expertise, and healthcare economics will all have significant influence on practice
Laparoscopic cholecystectomy is the current gold standard for surgical removal of the Gall bladder, particularly in benign pathologies. Hence, it is necessary to highlight some steps to accomplish this procedure successfully while avoiding pitfalls.
The presence of haematuria may be the sole symptom of an underlying disease, either benign or malignant. It is one of the most common presentations of patients with urinary tract diseases and of patients referred for urinary imaging. Painless visible haematuria (VH) is the commonest presentation of bladder cancer.
Post cholecystectomy pancreatitis: a misleading entity KETAN VAGHOLKAR
Cholecystectomy is one of the commonest hepatobiliary procedures performed in general surgical practice. Both laparoscopic as well as open cholecystectomies have their place in modern-day surgical practice. Post cholecystectomy syndrome is a known entity affecting approximately 20% of patients who have undergone cholecystectomy. Post cholecystectomy pancreatitis is an uncommon and rare complication. A case of acute early post cholecystectomy pancreatitis is presented to create an awareness of this rare but misleading and morbid complication.
Laparoscopic cholecystectomy is the current gold standard for surgical removal of the Gall bladder, particularly in benign pathologies. Hence, it is necessary to highlight some steps to accomplish this procedure successfully while avoiding pitfalls.
The presence of haematuria may be the sole symptom of an underlying disease, either benign or malignant. It is one of the most common presentations of patients with urinary tract diseases and of patients referred for urinary imaging. Painless visible haematuria (VH) is the commonest presentation of bladder cancer.
Post cholecystectomy pancreatitis: a misleading entity KETAN VAGHOLKAR
Cholecystectomy is one of the commonest hepatobiliary procedures performed in general surgical practice. Both laparoscopic as well as open cholecystectomies have their place in modern-day surgical practice. Post cholecystectomy syndrome is a known entity affecting approximately 20% of patients who have undergone cholecystectomy. Post cholecystectomy pancreatitis is an uncommon and rare complication. A case of acute early post cholecystectomy pancreatitis is presented to create an awareness of this rare but misleading and morbid complication.
This presention is about gastroscopy and colonoscopy. Detailed explanations are give along with two videos that shows the procedure. The slide also explains about how the procedure is done and for who it is done.
A colonoscopy is an exam used to look for changes — such as swollen, irritated tissues, polyps or cancer — in the large intestine (colon) and rectum.
During a colonoscopy, a long, flexible tube (colonoscope) is inserted into the rectum. A tiny video camera at the tip of the tube allows the doctor to view the inside of the entire colon.
If necessary, polyps or other types of abnormal tissue can be removed through the scope during a colonoscopy. Tissue samples (biopsies) can be taken during a colonoscopy as well
Radiological investigation of billiary tact 01Kajal Jha
The name biliary tract is used to refer to all of the ducts, structures and organs involved in the production, storage and secretion of bile.
Bile canaliculi >> Canals of Hering >> intrahepatic bile ductule (in portal tracts / triads) >> interlobular bile ducts >> left and right hepatic ducts >>
These merge to form the common hepatic duct
This exits the liver and joins with the cystic duct from gall bladder
Together these form the common bile duct which joins the pancreatic duct
These pass through the ampulla of Vater and enter the duodenum
COLONOSCOPY- A PICTORIAL OVERVIEW
• Dear viewers,
• Greetings from “Surgical Educator”
• This week I have uploaded a video on Colonoscopy- the Lower GI Endoscopy.
• In this episode, I showed only the colonoscopic features of common pathologies in colon and rectum.
• I restricted my talk to the essential minimum that an undergraduate medical student must know about the Colonoscopy.
• I discussed about the diagnostic and therapeutic procedures you can do with the Colonoscopy.
• I hope it would be interesting and very useful to all my viewers.
• You can access this video in the following links:
• surgicaleducator.blogspot.com youtube.com/c/surgicaleducator
• Thank you for watching the video.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
2. Introduction:
EUS-guided liver biopsy has moved to the fore, becoming more widespread
, replacing liver biopsy performed via transabd or transjugular routes.
With the introduction of EUS-guided portal pressure measurement
procedures (most include a liver biopsy as well), this trend is likely to
increase with time.
EUS-guided liver biopsy is not as simple or as straightforward as it may
seem at first glance.
3. Practical steps:1
1. Talk to your hepatologists & other referring physicians to inform them
that you are doing EUS-guided liver biopsy (EUS-LB).
We found that our gastroenterology&hepatology colleagues who were not
doing percutaneous liver biopsies any more were agreeable with
transferring the liver biopsy workload to the EUS team.
Be sure to inform the hepatologists that portal pressure gradient
measurements can be made during the same EUS session, avoiding the
more invasive transjugular technique.
Talk to your pediatric gastroenterologists as well, to let them know that
this procedure is available, inasmuch as it is likely to be less anxiety
provoking for the younger patient to have a sedated procedure.
4. Advantages:
A. Clinical care remains in the gastroenterology/ hepatology department.
B. Real-time US needle guidance appears to be safer than other
approaches to liver biopsy.
C. The sedated procedure decreases patient anxiety&can result in
increased patient satisfaction.
D. Bilobar biopsy is easily accomplished, decreasing the potential for
sampling error.
E. Additional endoscopic procedures, including EGD,EUS, or colonoscopy
can be done during the same endoscopic session, resulting in time, effort,&
money savings for the patient, physician&healthcare system.
5. Practical steps:2
2. Talk to pathologists that you will be doing EUS-guided liver biopsies.
EUSLB specimens meet accepted benchmarks for adequacy in terms of
specimen length& complete portal triad count,comparable with or even
better than specimens obtained by PC or transjugular liver biopsy.
Pathologists independently noted an improvement in sample quality using
EUS-LB, particularly when using the core needle.
The core needle provide excellent long cores, even if cirrhosis.
6. Practical steps:3
3. Check procedure indication& need for additional procedures during it.
It is common for a patient undergoing a liver biopsy to have an indication
for another endoscopic evaluation,as EGD to rule out varices,investigate
dyspepsia, or rule out Barrett’s& others.
A colonoscopy may be required for screening or surveillance reasons.
There may be a need for EUS for pancreatic abns seen on imaging,
evaluation of biliary disease as bile duct dilatation, to rule out gallbladder
stones/sludge, or suspected biliary pain, or portal pressure measurement.
7. Practical steps:4
4. Check procedure contraindications.
In general, we require an INR of <1.5& a platelet count of 50,000 before
liver biopsy.
The patient should not be taking anticoagulation or antiplatelet agents for
an appropriate length of time before the procedure. If that is not possible,
a transjugular approach may be required.
Large-volume ascites is thought to be a contraindication to liver biopsy.
Previous gastric surgery (eg, Rouxen- Y gastric bypass) is not a
contraindication because a left lobe liver biopsy can be readily done even
in patients with partial gastric resection.
Known liver cirrhosis is not strictly a contraindication, but it is uncommon
for a patient with cirrhosis to need a liver biopsy.
8. Practical steps:5
5. Select the biopsy needle.
Usually, 19-gauge EUS needles are used for EUS-LB; 22-gauge needles
produce specimens that are subject to fragmentation during specimen
processing¬ preferred.
A 19-gauge “core needle” (fine-needle biopsy) is preferred over a 19-gauge
FNA needle, with better LB specimens.
If a 19-gauge FNB needle is not available, a 19-gauge FNA needle should
be adequate, although it works best if used with the “wet suction” method.
9. Practical steps:6
6. Prepare the biopsy needle.
We have found that “wet suction” provides higher tissue yields compared
with dry suction.
For wet suction, the needle stylet is removed.
The needle is then flushed with a small amount of a standard heparin
flush.
The suction syringe is filled with 1 to 2 mL of water, the stopcock is turned
to off& then the suction syringe is set at a full suction setting,this is then
mounted on the primed needle.
A stylet slow-pull technique is preferred by some endosonographers, but it
is still advantageous to flush the needle with heparin first (and then
reinsert the stylet) to prevent blood clotting in the needle
10. Practical steps:7
7. Assess the biopsy target in the liver& avoid inadvertent splenic biopsy.
Be certain to distinguish the left lobe of the liver from the spleen, which is
in a similar location in the proximal stomach, can be enlarged in chronic
liver disease& may have a similar US echotexture to that of the liver.
The left lobe can be positively identified by known landmarks (hepatic
veins, portal venous structures),although portal structures may be
obscured in livers with significant fat.
Inadvertent splenic puncture can result in possible bleeding adverse effect,
particularly if splenic hilar vessels are in the path of needle insertion.
The right hepatic lobe target is easily found with the echoendoscope tip
placed in the duodenal bulb& torqued counterclockwise
11. Practical steps:8
8. Use an optimal& safe needle biopsy technique.
Find a trajectory for needle travel into the liver that avoids sizable vessels.
This may be 2-3 cm, or in some cases could be longer than 3.5 cm.
It is important to realize that in some cases a very long needle throw will
not be possible.
Both endoscope knobs are locked&elevator is used to deflect the needle.
It may be advantageous add to some endoscope, pull the big wheel back &
assistant hold the endoscope at the bite block to prevent recoiling with
initial needle puncture.
The needle is introduced 1 cm into parenchyma with short rapid move.
The initial needle stroke needs to be “high velocity” to get the needle
through the gastric (or duodenal) wall, but the initial stroke should not be
too deep. The gastric wall can be a little hard to puncture on occasion& the
echoendoscope adjustments described above allow the needle to enter the
liver in as nearly a perpendicular approach as possible.
12. Practical steps:8
Once the needle is in the liver, the suction is applied by turning the
stopcock to “open,”& the needle is advanced with slow& steady
movements to& fro 3-4 times in the liver. A 3-cm course of needle travel is
excellent& sufficient; but it can be longer if no vessels are seen beyond this
point.
After the biopsy& before the needle is removed from the liver, the suction
is turned off. The needle is removed from the echoendoscope in
preparation for sample collection.
We usually do bilobar liver biopsy,advantageous in biopsies done for
nonalcoholic steatohepatitis.
Unilobar biopsy may be sufficient for other indications for liver biopsy.
If the sample that is obtained appears inadequate in terms of specimen
length or excessive fragmentation, a second trial done.
13. Practical steps:9
9. Retrieve specimen without introducing fragmentation&assess adequacy
of biopsy.
Excessive handling of the specimen should be avoided.
It is common that the specimen will be admixed with blood.
If the needle was primed with heparin, then the blood is less likely to form
a “noodle-like” clot.
A collection sieve allows blood to be washed from the specimen&rapid
adequacy review is possible.
A purpose made device has been developed for liver biopsy sample
collection kit has a peel-off mesh that catches the liver cores& can be
transferred directly to formalin&immediate review of the amount of tissue
obtained is possible.
Alternatively, the contents of the needle can be expressed straight into the
jar of formalin.
Assessment of the adequacy of the specimen may be more difficult because
admixed blood can obscure the view of the liver ores in the jar.
14. Practical steps:10
10. Assess the patient after biopsy.
1 hr of recovery is sufficient for EUS-LB, even if bilobar biopsy is done.
About 30-40% of patients experience abdominal pain after EUS-LB, most
from local peritoneal irritation by a small amount of blood that may be
coming from the puncture sites,typically self limited, although some
patients require a single dose of opiates,typically use 1 mg hydromorphone
hydrochloride, although 50-75 mg of fentanyl is also effective.
Patients are typically discharged after 1 hr of observation& return to a
normal diet.
Pain that is persistent is first managed with a second dose of opiate
analgesia,if not effective, we usually perform contrast-enhanced liver CT
to determine whether a bleeding adverse event has occurred&even if there
is evidence of bleeding or intrahepatic hematoma, it is usually self limited&
does not usually require interventional radiologic management by vascular
embolization, although we do admit the patients for at least overnight.